Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S3751Referred to Committee

Prescription Drug Supply Chain Pricing Transparency Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-01-29
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Michael F. Bennet
Michael F. Bennet
Democrat · CO · Senator
Votes with party: 60.6% (317 recorded votes)

Full profile: /officials/B001267

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • James Lankford (R-OK)Original· 2026-01-29

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Finance.

2026-01-29

Source: Congress.gov

Plain-English Summary

This bill would require drug manufacturers, wholesalers, and pharmacy benefit managers to disclose detailed pricing information throughout the prescription drug supply chain, making it easier to see how much money each company makes from drug sales. By pulling back the curtain on these hidden markups and fees, the bill aims to help patients, insurers, and policymakers understand why prescription drugs cost so much and identify where prices are being inflated. The transparency could put pressure on companies to justify high prices and potentially help lawmakers design policies to lower drug costs.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Affected Industries

Industries and interest groups with a stake in how this bill is resolved. Compare with each member's outside-money backers on their finance page.

Pharmaceutical

Why this matters: Look up any member who voted on this bill and check their finance page — do the industries listed above match the groups funding their campaigns? That's the kind of connection this tool is built to help you find.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S4589OPEN Act
    Referred to Committee · 2026-05-20
  • S4590KIDS Act
    Referred to Committee · 2026-05-20
  • S4596TRUST Act
    Referred to Committee · 2026-05-20
  • S4575SMART Community Policing Act
    Referred to Committee · 2026-05-19